NYSE Arca · LABD

Direxion Daily S&P Biotech Bear 3X ETF (LABD)

$7.30+9.61%
Close Nov 12, 2026 · split-adjusted
Nov 12, 2026$7.30▼ 72.77% in range
Nov 12, 2025Low $5.90 · High $28.22Nov 12, 2026
What changed · written from our data
As of Nov 12, 2026

Direxion Daily S&P Biotech Bear 3X ETF closed at $7.30 on Nov 12, up 9.61%, 74.1% below its 52-week closing high. Volume of 35.3M shares was 1.48× its 20-day average (above normal).

Split-adjusted performance: -15.5% over one month, -45.9% over six months, -72.8% over one year.

Short interest was 2.1M shares at the Oct 30 settlement, down 22.9% from the prior report (1.0 days to cover).

Market cap$67.9M9.3M shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yield3.87%$0.0707 last paid
52-week range5.90 – 28.22−74.1% from high
Volume35.3M1.48× 20-day avg
Volatility · 60d98.5%Annualised
Short % of float—1.0 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W −6.8%1M −15.5%3M −3.6%6M −45.9%YTD −65.3%1Y −72.8%3Y −96.5%5Y −95.8%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short2.1M−22.9% vs prior
Days to cover1.0Settled Oct 30
% of float—
Short vol. 10d39.6%of daily volume

News about Direxion Daily S&P Biotech Bear 3X ETF

All news →

No recent articles focused on Direxion Daily S&P Biotech Bear 3X ETF.

Quick answers

What is LABD's market cap?
$67.94M, based on the Nov 12 close of $7.30.
Does Direxion Daily S&P Biotech Bear 3X ETF pay a dividend?
Yes. The latest regular dividend was $0.0707 per share (ex-date Sep 22), an annualised yield of 3.87%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology